Glp1r-Lepr coexpressing neurons modulate the suppression of food intake and body weight by a GLP-1/leptin dual agonist
Authors:
- Joseph Polex-WolfJPJoseph Polex-Wolf
- Kristine DeiblerKDKristine Deibler
- Wouter Frederik Johan HogendorfWHWouter Frederik Johan Hogendorf
- Sarah BauSBSarah Bau
- Carsten Enggaard StidsenCSCarsten Enggaard Stidsen
- Christian Wenzel TornøeCTChristian Wenzel Tornøe
- Sofia LundhSLSofia Lundh
- Abigail J. TomlinsonATAbigail J. Tomlinson
- 4 December 2024
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 16 (776) , eadk4908
Abstract
Glucagon-like peptide-1 (GLP-1) and leptin signal recent feeding and long-term energy stores, respectively, and play complementary roles in the modulation of energy balance. Previous work using single-cell techniques in mice revealed the existence of a population of leptin receptor ( Lepr )–containing dorsomedial hypothalamus (DMH) neurons marked by the expression of GLP-1 receptor ( Glp1r ; LepR Glp1r neurons) that play important roles in the control of feeding and body weight by leptin. Here, we demonstrate the existence of a population of LepR Glp1r neurons in the DMHs of nonhuman primates (NHPs), suggesting the potential translational relevance of these neurons. Consequently, we developed a GLP-1R/LepR dual agonist and demonstrated the physiological activity of both components in vivo using leptin-deficient and Lepr- deficient murine models. We further found roles for LepR Glp1r neurons in mediating the dual agonist’s efficacy on food intake and body weight loss. Ablating Lepr in Glp1r -expressing neurons (Lepr Glp1r KO mice) abrogated the suppression of food intake by the dual agonist. Furthermore, reactivation of Glp1r expression in Lepr neurons on an otherwise Glp1r -null background (Glp1r Lepr Re mice) was sufficient to permit the suppression of food intake and body weight by the dual agonist. Hence, LepR Glp1r neurons represent targets for a GLP-1R/LepR dual agonist that potently reduces food intake and body weight.Keywords
This publication has 32 references indexed in Scilit:
- The expanding incretin universe: from basic biology to clinical translationDiabetologia, 2023
- Glucagon-like peptide-1 receptor co-agonists for treating metabolic diseaseMolecular Metabolism, 2021
- Distinct Neural Sites of GLP-1R Expression Mediate Physiological versus Pharmacological Control of Incretin ActionCell Reports, 2019
- Sensory Neurons that Detect Stretch and Nutrients in the Digestive SystemCell, 2016
- Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 DiabetesJAMA, 2015
- Pharmacology, Physiology, and Mechanisms of Incretin Hormone ActionCell Metabolism, 2013
- Engineering and characterization of the long‐acting glucagon‐like peptide‐1 analogue LY2189265, an Fc fusion proteinDiabetes/Metabolism Research and Reviews, 2010
- An allelic series for the leptin receptor gene generated by CRE and FLP recombinaseMammalian Genome, 2004
- Recombinant Leptin for Weight Loss in Obese and Lean AdultsJAMA, 1999
- Distribution of glucagonlike peptide I (GLP‐I), glucagon, and glicentin in the rat brain: An immunocytochemical studyJournal of Comparative Neurology, 1988